ArchivesMagazine - 23 Dec 2020All eyes on AstraZeneca as markets wait for vaccine approval A green light could help to calm markets shocked by tighter government restrictions pre-Christmas 23 December 2020|News|by Martin Gamble Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email < New fears for retail, leisure and oil sectors as Covid bites Is it time to take bitcoin more seriously? > Issue: 23 Dec 2020 - Page 8 | Contents Next: Is it time to take bitcoin more seriously? Previous: New fears for retail, leisure and oil sectors as Covid bites Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email Martin Gamble Issue Contents Ask Tom When can I claim my state pension? Book reviews Terry Smith on lessons learnt in his first 10 years at Fundsmith Editor's View Is it time to take bitcoin more seriously? Feature Top stocks for 2021 How our 2020 stock portfolio stayed afloat despite Covid The year Baillie Gifford took over the investing world Is China still a developing economy? Emerging markets: Views from the experts The best performing stocks of 2020 The trends that will shape a continuing ESG boom in 2021 First-time Investor Getting you started: Ways to make money from investing Funds Fund and investment trust picks for 2021 Great Ideas Stock pick for 2021: Alibaba Stock pick for 2021: BHP Stock pick for 2021: Convatec Stock pick for 2021: Diageo Stock pick for 2021: Eurofins Scientific Stock pick for 2021: Inspecs Stock pick for 2021: Ocado Stock pick for 2021: PZ Cussons Stock pick for 2021: Qinetiq Stock pick for 2021: RWS Stock pick for 2021: Tracsis Stock pick for 2021: JD Wetherspoon News New fears for retail, leisure and oil sectors as Covid bites All eyes on AstraZeneca as markets wait for vaccine approval The underappreciated risks to markets in 2021 Personal Finance DIY investors are cautiously confident for 2021 Russ Mould Is food one reason why inflation could crop up in 2021?
